You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

235 Items

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

Document Status: Current

Mar 2025

Target Wait Times for Cancer Surgery in Ontario

Document Status: Current
ID: GL-C50-03

Apr 2006

The Role of Endolaryngeal Surgery (With or Without Laser) versus Radiotherapy in the Management of Early (T1) Glottic Cancer

Document Status: Current
ID: 5-2
Version: 2

Oct 2023

The Role of High Dose Rate Brachytherapy in the Palliation of Symptom in Patients with Non-Small Cell Lung Cancer

Document Status: Current
ID: 7-16
Version: 4

Dec 2022

The Role of Primary Tumour Location in the Selection of Biologics for the Treatment of Unresectable Metastatic Colorectal Cancer: An Endorsement of a Canadian Consensus Statement

Document Status: Current
ID: GL END 2-31

Jul 2018

The Use of Adjuvant Radiation Therapy for Curatively Resected Cutaneous Melanoma

Document Status: Current
ID: 8-9

Jan 2016

The Use of Indoor Tanning Devices and the Risk of Developing Cutaneous Malignant Melanoma: A Systematic Review and Clinical Practice Guideline

Document Status: Current
ID: 8-8
Version: 2

Updated

Sep 2025

The Use of Molecular Tools for Identifying and Guiding Treatment of Cancers of Unknown Primary

Document Status: Current
ID: MOTAC-7

Jan 2025

The Utility of PET/CT in Breast Cancer (Stages II-IV): An Evidence Summary

Document Status: Current
ID: PET ES-14

Jan 2014

The Utility of PET/CT in Colorectal Cancer Metastasis: An Evidence Summary

Document Status: Current
ID: PET ES-15

Jan 2014

The Utility of Positron Emission Tomography in Epilepsy

Document Status: Current
ID: PET 13

Jan 2015

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: American Society of Clinical Oncology (ASCO) and Ontario Health (Cancer Care Ontario) Joint Guideline Update

Document Status: Current
ID: 7-A-2018-3

Feb 2021